- Home
- CNSP vs CREG Comparison
CNSP vs CREG Comparison
Compare CNSP & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- CREG
- Stock Information
- Founded
- CNSP 2017
- CREG 1980
- Country
- CNSP United States
- CREG China
- Employees
- CNSP N/A
- CREG N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- CREG Power Generation
- Sector
- CNSP Health Care
- CREG Utilities
- Exchange
- CNSP Nasdaq
- CREG Nasdaq
- Market Cap
- CNSP 5.6M
- CREG 6.1M
- IPO Year
- CNSP 2019
- CREG N/A
- Fundamental
- Price
- CNSP $1.25
- CREG $0.63
- Analyst Decision
- CNSP Hold
- CREG
- Analyst Count
- CNSP 1
- CREG 0
- Target Price
- CNSP N/A
- CREG N/A
- AVG Volume (30 Days)
- CNSP 332.7K
- CREG 78.1K
- Earning Date
- CNSP 05-14-2025
- CREG 05-13-2025
- Dividend Yield
- CNSP N/A
- CREG N/A
- EPS Growth
- CNSP N/A
- CREG N/A
- EPS
- CNSP N/A
- CREG N/A
- Revenue
- CNSP N/A
- CREG N/A
- Revenue This Year
- CNSP N/A
- CREG N/A
- Revenue Next Year
- CNSP N/A
- CREG N/A
- P/E Ratio
- CNSP N/A
- CREG N/A
- Revenue Growth
- CNSP N/A
- CREG N/A
- 52 Week Low
- CNSP $1.21
- CREG $0.53
- 52 Week High
- CNSP $800.00
- CREG $1.57
- Technical
- Relative Strength Index (RSI)
- CNSP 30.28
- CREG 39.38
- Support Level
- CNSP $1.28
- CREG $0.67
- Resistance Level
- CNSP $1.46
- CREG $0.81
- Average True Range (ATR)
- CNSP 0.38
- CREG 0.07
- MACD
- CNSP -0.12
- CREG -0.01
- Stochastic Oscillator
- CNSP 1.18
- CREG 27.16
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.